Latest News

Date Title Topic
01 Sep 2017 FDA Approves Tisagenlecleucel for B-Cell ALL and Tocilizumab for Cytokine Release Syndrome Haematologic malignancies - Palliative and supportive care - Cancer Immunology and Immunotherapy
01 Sep 2017 ESMO 2017 Media Alert: Updated ESMO Magnitude of Clinical Benefit Scale Set to Evaluate Single-arm Studies
31 Aug 2017 Indels Provide Highly Immunogenic Neoantigens and May Be Potential Biomarkers of Immunotherapy Response Translational research - Cancer Immunology and Immunotherapy
31 Aug 2017 ESMO 2017 Press Release: IFCT-0302 results question role of CT-scan in NSCLC post-surgery follow-up Lung and other thoracic tumours
30 Aug 2017 NICE Issues Technology Appraisal Guidance on Olaratumab in Combination with Doxorubicin for Treating Advanced STS Sarcomas - Anticancer agents & Biologic therapy
30 Aug 2017 Media Alert: ESMO 2017 Poster and Oral Abstracts Published Online Tonight
29 Aug 2017 Adolescent and Young Adult Cancer Survivors Are Less Likely to Have HPV-Vaccination than Peers Cancer in Special Situations - Epidemiology/Etiology/Cancer Prevention
23 Aug 2017 Concept Paper on Development and Lifecycle of Personalised Medicines and Companion Diagnostics Personalised medicine - Bioethics, legal and economic issues
22 Aug 2017 FDA Approves Inotuzumab Ozogamicin for Relapsed or Refractory B-Cell Precursor ALL Haematologic malignancies - Anticancer agents & Biologic therapy
21 Aug 2017 FDA Expands Ibrutinib Indications to Chronic GVHD Cancer in Special Situations - Haematologic malignancies - Anticancer agents & Biologic therapy
18 Aug 2017 FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
18 Aug 2017 FDA Approves Liposome-Encapsulated Combination of Daunorubicin-Cytarabine for Adults with Some Types of Poor Prognosis AML Haematologic malignancies - Anticancer agents & Biologic therapy
17 Aug 2017 Liquid Biopsy Screening for Nasopharyngeal Carcinoma Epidemiology/Etiology/Cancer Prevention - Head and neck cancers
16 Aug 2017 EU Commission Launches Public Consultation on Health and Care in the Digital Single Market Bioethics, legal and economic issues
15 Aug 2017 FDA Grants Regular Approval to Enasidenib for the Treatment of Relapsed or Refractory AML Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy